Cardiovascular Safety of Ranibizumab for Diabetic Macular Edema Still Unclear

Uncertainty lingers about the cardiovascular safety of intravitreal ranibizumab injections for diabetic macular edema, a pooled analysis of clinical trials shows.
Reuters Health Information

Full Story →